Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Amr Fergany, MD, is a Staff physician with the Glickman Urological and Kidney Institute at Cleveland Clinic's main campus. He has been with the urologic oncology and the laparoscopy and robotics sections full time since 2002 after one of several sabbaticals teaching in his native Cairo, Egypt. He started with the Cleveland Clinic when he became a research fellow in 1991. His specialty interests include laparoscopic surgery and urologic oncology.
Dr. Fergany received his medical degree from Cairo University, graduating with the Professor Abdel Wahab Mooro Award for highest total surgery grades and the Professor Baden Philip Award for highest clinical medicine grades in his class. He speaks French in addition to Arabic and English.
He has authored dozens of research articles in leading peer-reviewed journals as well as book chapters and videos. He has had several teaching assignments, including his current faculty appointment with the Department of Anatomy in the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, teaching undergraduate anatomy of the kidney and abdominal ureter. He also received the Teacher of the Year Award for his work at the Glickman Urological Institute. Dr. Fergany is a Diplomate of the American Board of Urology.
Dr. Fergany has also received the Cleveland Clinic’s Bruce Hubbard Stewart Award for Humanistic Medicine, honoring a staff physician who exemplifies sensitive and concerned treatment of patients.
Open and laparoscopic surgery for kidney cancer, bladder cancer, and prostate cancer, urologic oncology, adrenal disorders, testicular cancer, transitional cell carcinoma, urethral cancer, enlarged prostate/benign prostatic hyperplasia
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/4/2016, Dr. Fergany has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.